Search Results - Kurtis D. Davies

Refine Results
  1. 1
    Molecular Pathways: ROS1 Fusion Proteins in Cancer

    Molecular Pathways: ROS1 Fusion Proteins in Cancer by Kurtis D. Davies, Robert C. Doebele

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    L2086F Mutant ROS1-Rearranged NSCLC Resistant to Repotrectinib Responds to Cabozantinib: A Case Report

    L2086F Mutant ROS1-Rearranged NSCLC Resistant to Repotrectinib Responds to Cabozantinib: A Case Report by Urs Weber, Kurtis D. Davies, D. Ross Camidge

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    <i>MET</i>Exon 14 Skipping Mutations in Non–Small-Cell Lung Cancer: An Overview of Biology, Clinical Outcomes, and Testing Considerations

    <i>MET</i>Exon 14 Skipping Mutations in Non–Small-Cell Lung Cancer: An Overview of Biology, Clinical Outcomes, and Testing Considerations by Mark A. Socinski, Nathan A. Pennell, Kurtis D. Davies

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Dual Mechanism of a Natural CaMKII Inhibitor

    Dual Mechanism of a Natural CaMKII Inhibitor by Rebekah S. Vest, Kurtis D. Davies, Heather O’Leary, J. David Port, K. Ulrich Bayer

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    DNA-Based versus RNA-Based Detection of MET Exon 14 Skipping Events in Lung Cancer

    DNA-Based versus RNA-Based Detection of MET Exon 14 Skipping Events in Lung Cancer by Kurtis D. Davies, Aprille Lomboy, Carolyn A. Lawrence, Michael Yourshaw, Gregary T. Bocsi, D. Ross Camidge, Dara L. Aisner

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Radiation Induces Acute Alterations in Neuronal Function

    Radiation Induces Acute Alterations in Neuronal Function by P.H. Wu, Steven J. Coultrap, Chelsea C. Pinnix, Kurtis D. Davies, Ramesh Tailor, Kian Ang, Michael Browning, David R. Grosshans

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Dramatic Response to Crizotinib in a Patient With Lung Cancer Positive for an <i>HLA-DRB1-MET</i> Gene Fusion

    Dramatic Response to Crizotinib in a Patient With Lung Cancer Positive for an <i>HLA-DRB1-MET</i> Gene Fusion by Kurtis D. Davies, Terry L. Ng, Adriana Estrada‐Bernal, Anh T. Le, Peter R. Ennever, D. Ross Camidge, Robert C. Doebele, Dara L. Aisner

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Chk1 inhibition and Wee1 inhibition combine synergistically to impede cellular proliferation

    Chk1 inhibition and Wee1 inhibition combine synergistically to impede cellular proliferation by Kurtis D. Davies, P. LouAnn Cable, Jennifer Garrus, Francis X. Sullivan, Ira von Carlowitz, Yvan Le Huérou, Eli Wallace, Richard Woessner, Stefan Gröss

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples

    Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples by Kurtis D. Davies, Anh‐Tuan Le, Jamie Sheren, Hala Nijmeh, Katherine Gowan, Kenneth L. Jones, Marileila Varella‐Garcia, Dara L. Aisner, Robert C. Doebele

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Small Molecule Inhibition of MERTK Is Efficacious in Non–Small Cell Lung Cancer Models Independent of Driver Oncogene Status

    Small Molecule Inhibition of MERTK Is Efficacious in Non–Small Cell Lung Cancer Models Independent of Driver Oncogene Status by Christopher T. Cummings, Weihe Zhang, Kurtis D. Davies, Gregory D. Kirkpatrick, Dehui� Zhang, Deborah DeRyckere, Xiaodong Wang, Stephen V. Frye, H. Shelton Earp, Douglas K. Graham

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancers

    Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancers by Marisa R. Moroney, Kurtis D. Davies, Adam C. Wilberger, Jeanelle Sheeder, Miriam D. Post, Amber Berning, Christine M. Fisher, Carolyn Lefkowits, Saketh R. Guntupalli, Kian Behbakht, Bradley R. Corr

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer

    Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer by Jill J. Bastman, Hilary S. Serracino, Yuwen Zhu, Michelle R. Koenig, Valerica Mateescu, Sharon B. Sams, Kurtis D. Davies, Christopher D. Raeburn, Robert C. McIntyre, Bryan R. Haugen, Jena D. French

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Resistance to ROS1 Inhibition Mediated by EGFR Pathway Activation in Non-Small Cell Lung Cancer

    Resistance to ROS1 Inhibition Mediated by EGFR Pathway Activation in Non-Small Cell Lung Cancer by Kurtis D. Davies, Sakshi Mahale, David P. Astling, Dara L. Aisner, Anh T. Le, Trista K. Hinz, Aria Vaishnavi, Paul A. Bunn, Lynn E. Heasley, Aik Choon Tan, D. Ross Camidge, Marileila Varella‐Garcia, Robert C. Doebele

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Identifying and Targeting <i>ROS1</i> Gene Fusions in Non–Small Cell Lung Cancer

    Identifying and Targeting <i>ROS1</i> Gene Fusions in Non–Small Cell Lung Cancer by Kurtis D. Davies, Anh T. Le, Mariana F. Theodoro, Margaret C. Skokan, Dara L. Aisner, Eamon M. Berge, Luigi Terracciano, Federico Cappuzzo, Matteo Incarbone, Massimo Roncalli, Marco Alloisio, Armando Santoro, D. Ross Camidge, Marileila Varella‐Garcia, Robert C. Doebele

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors

    Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors by Jessica Lake, Andrew M. Donson, Eric Prince, Kurtis D. Davies, Anandani Nellan, Adam L. Green, Jean M. Mulcahy Levy, Kathleen Dorris, Rajeev Vibhakar, Todd C. Hankinson, Nicholas K. Foreman, Mark D. Ewalt, Bette K. Kleinschmidt‐DeMasters, Lindsey M. Hoffman, Ahmed Gilani

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Resistance Mechanisms to Targeted Therapies in <i>ROS1</i>+ and <i>ALK</i>+ Non–small Cell Lung Cancer

    Resistance Mechanisms to Targeted Therapies in <i>ROS1</i>+ and <i>ALK</i>+ Non–small Cell Lung Cancer by Caroline E. McCoach, Anh T. Le, Katherine Gowan, Kenneth A. Jones, Laura Schubert, Andrea E. Doak, Adriana Estrada‐Bernal, Kurtis D. Davies, Daniel T. Merrick, Paul A. Bunn, W. Tom Purcell, Rafał Dziadziuszko, Marileila Varella‐Garcia, Dara L. Aisner, D. Ross Camidge, Robert C. Doebele

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer

    Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer by Sana D. Karam, Krishna Reddy, Patrick J. Blatchford, Tim Waxweiler, Alicia M. DeLouize, Ayman Oweida, Hilary Somerset, Carrie B. Marshall, Christian D. Young, Kurtis D. Davies, Madeleine Kane, Aik Choon Tan, Xiaojing Wang, Antonio Jimeno, Dara L. Aisner, Daniel W. Bowles, David Raben

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Clinical Utility of Cell-Free DNA for the Detection of <i>ALK</i> Fusions and Genomic Mechanisms of ALK Inhibitor Resistance in Non–Small Cell Lung Cancer

    Clinical Utility of Cell-Free DNA for the Detection of <i>ALK</i> Fusions and Genomic Mechanisms of ALK Inhibitor Resistance in Non–Small Cell Lung Cancer by Caroline E. McCoach, Collin M. Blakely, Kimberly C. Banks, Benjamin Levy, Ben M. Chue, Victoria M. Raymond, Anh T. Le, Christine E. Lee, Joseph A. Diaz, Saiama N. Waqar, W. Thomas Purcell, Dara L. Aisner, Kurtis D. Davies, Richard B. Lanman, Alice T. Shaw, Robert C. Doebele

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases

    EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases by Aria Vaishnavi, Laura Schubert, Uwe Rix, Lindsay A. Marek, Anh T. Le, Stephen B. Keysar, Magdalena J. Glogowska, Matthew A. Smith, Severine Kako, Natália J. Sumi, Kurtis D. Davies, Kathryn E. Ware, Marileila Varella‐Garcia, Eric B. Haura, Antonio Jimeno, Lynn E. Heasley, Dara L. Aisner, Robert C. Doebele

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid Tumors

    Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid Tumors by Julie W. Reeser, Dorrelyn M. Martin, Jharna Miya, Esko A. Kautto, E. Lyon, Eliot Y. Zhu, Michele R. Wing, Amy Smith, Matthew Reeder, Eric Samorodnitsky, Hannah Parks, Karan R. Naik, Joseph M. Gozgit, Nicholas B. Nowacki, Kurtis D. Davies, Marileila Varella‐Garcia, Lianbo Yu, Aharon G. Freud, Joshua F. Coleman, Dara L. Aisner, Sameek Roychowdhury

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: